Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer
- PMID: 7361710
- DOI: 10.1093/ajcp/73.3.313
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer
Abstract
Although papillary forms of intraductal cancer are a common component of amny mammary cancers, invasive papillary cancer of the breast is relatively rare. Only 35 examples were encountered in the specimens obtained from 1603 women participating in a prospective randomized study of invasive mammary cancer. Contingency-table analysis disclosed that invasive papillary cancer, as opposed to the non-papillary histologic types, is significantly more likely to show circumscription, cytoplasmic oxyphilia, microcalcification, intermediate histologic grade, moderate or marked mucin and an intraductal component of papillary type. Although patients who have invasive papillary cancer are frequently judged by clinical criteria to have regional nodal metastases, in pathologic analysis these metastases are not commonly found and, if present, involve fewer than four nodes. There is a significant frequency of marked sinus histiocytosis in regional nodes. The lesion occurs with a significantly high frequency among non-Caucasian and postmenopausal women. Only three patients with invasive papillary cancer experienced treatment failure after five years of observation. Life-table probabilities showed that the treatment failure rate was significantly lower for the group of patients who had any other histologic type, and in this regard invasive papillary cancer was similar to the tubular and mucinous varieties. Although apocrine metaplasia, fibrous supporting stalks and cellular differentiation have been espoused as important criteria distinguishing intraductal papi-loma from intraductal cancer, these features were also not uncommonly observed in the examples of invasive papillary cancer studied. It is concluded that invasive papillary cancer represents a unique histologic type of invasive mammary cancer attendant with a favorable prognosis.
Similar articles
-
Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer.Am J Clin Pathol. 1976 Jan;65(1):21-30. doi: 10.1093/ajcp/65.1.21. Am J Clin Pathol. 1976. PMID: 174420
-
The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).Cancer. 1975 Jul;36(1):1-85. doi: 10.1002/1097-0142(197507)36:1<1::aid-cncr2820360102>3.0.co;2-4. Cancer. 1975. PMID: 173455
-
Scar cancers: pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4) - IX.Breast Cancer Res Treat. 1983;3(1):39-59. doi: 10.1007/BF01806233. Breast Cancer Res Treat. 1983. PMID: 6871481
-
Invasive Mammary Carcinoma With Mixed Invasive Papillary and Glycogen Rich Clear Cell Features.Int J Surg Pathol. 2018 Sep;26(6):569-572. doi: 10.1177/1066896918765651. Epub 2018 Mar 27. Int J Surg Pathol. 2018. PMID: 29580112 Review.
-
Cancer of the breast. Gross and histologic pathlogy.Major Probl Clin Surg. 1979;5:157-96. Major Probl Clin Surg. 1979. PMID: 222970 Review.
Cited by
-
Clinicopathological Characteristics and Survival Outcomes in Invasive Papillary Carcinoma of the Breast: A SEER Population-Based Study.Sci Rep. 2016 Apr 7;6:24037. doi: 10.1038/srep24037. Sci Rep. 2016. PMID: 27053333 Free PMC article.
-
Micropapillary breast carcinoma in comparison with invasive duct carcinoma. Does it have an aggressive clinical presentation and an unfavorable prognosis?BMC Cancer. 2024 Aug 12;24(1):992. doi: 10.1186/s12885-024-12673-0. BMC Cancer. 2024. PMID: 39129012 Free PMC article.
-
Unusual case of insitu (intracystic) papillary carcinoma of breast.World J Clin Cases. 2013 Oct 16;1(7):227-9. doi: 10.12998/wjcc.v1.i7.227. World J Clin Cases. 2013. PMID: 24340273 Free PMC article.
-
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.BMC Cancer. 2017 Dec 28;17(1):895. doi: 10.1186/s12885-017-3897-x. BMC Cancer. 2017. PMID: 29281999 Free PMC article.
-
Papillary carcinoma of the breast: an overview.Breast Cancer Res Treat. 2010 Aug;122(3):637-45. doi: 10.1007/s10549-010-0961-5. Epub 2010 Jun 4. Breast Cancer Res Treat. 2010. PMID: 20524058 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical